The dystrophin gene encodes several tissue–specific protein isoforms that are generated by alternative splicing and by transcription from at least three separate promoters. We have characterized the mutation in a new strain of mdx mice that results in aberrant splicing of both the 14 and 4.8 kilobase dystrophin mRNAs and disrupts expression of the muscle and brain 427K and nonmuscle 70K isoforms of dystrophin. In contrast, we have determined that expression of the 70K isoform is normal in the original mdx mutant. We have cloned the unique 5′ exon of the murine 4.8 kb mRNA and have analysed the tissue distribution and aberrant splicing of this transcript in the mdx3Cv mutant. This new mdx mutant will provide an improved model system for functional studies of the dystrophin C–terminus in muscle and nonmuscle tissues.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Hoffman, E.P., Brown, R.H. Jr., & Kunkel, L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–928 (1987).
Emery, A.E.H. Duchenne Muscular Dystrophy, Oxford Monographs on Medical Genetics No. 15, Oxford Medical Publications, Oxford, 1987).
Nudel, U. et al. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 337, 76–78 (1988).
Feener, C.A., Koenig, M. & Kunkel, L.M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338, 509–511 (1989).
Lederfein, D. et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc. natn. Acad. Sci. U.S.A. 89, 5346–5350 (1992).
Blake, D.J. et al. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Scwannoma cells. Hum. molec. Genet. 1, 103–110 (1992).
Koenig, M. et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. hum. Genet. 46, 498–506 (1989).
Gillard, E.F. et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am. J. hum. Genet. 45, 507–520 (1989).
Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G. & Campbell, K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315–319 (1990).
Bulfield, G., Siller, W.G., Wight, P.A. & Moore, K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. natn. Acad. Sci. U.S.A. 81, 1189–1192 (1984).
Chamberlain, J.S. et al. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 239, 1416–1418 (1988).
Sicinski, P. et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578–1580 (1989).
Bies, R.D. et al. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucl. Acids Res. 20, 1725–1731 (1992).
Chapman, V.M., Miller, D.M., Armstrong, D. & Caskey, C.T. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. natn. Acad. Sci. U.S.A. 86, 1292–1296 (1989).
Chamberlain, J.S., Farwell, N.J., Chamberlain, J.R., Cox, G.A. & Caskey, C.T. PCR analysis of dystrophin gene mutation and expression. J. Cell Biochem. 46, 255–259 (1991).
Green, M.R. Pre-mRNA splicing. Ann. Rev. Genet. 20, 671–708 (1986).
Roberts, R.G., Coffey, A.J., Bobrow, M. & Bentley, D.R. Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. Genomics 13, 942–950 (1992).
Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283–292 (1986).
Chamberlain, J.S. et al. Analysis of Duchenne muscular dystrophy mutations in mice and humans. In Cellular and Molecular Biology of Muscle Development, UCLA Symposia on Molecular and Cellular Biology (eds Stockdale, F. & Kedes, L.) 951–962 (Alan R. Liss, New York, 1989).
Lee, C.C., Pearlman, J.A., Chamberlain, J.S. & Caskey, C.T. Expression of recombinant dystrophin and its localization to the cell membrane. Nature 349, 334–336 (1991).
Danko, I., Chapman, V. & Wolff, J.A. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr. Res. 32, 128–131 (1992).
Stedman, H.H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536–539 (1991).
Metherall, J.E., Collins, F.S., Pan, J., Weissman, S.M. & Forget, B.G. Beta-zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron. EMBO J. 5, 2551–2557 (1986).
Fu, X., Colgan, J.D. & Manley, J.L. Multiple cis-acting sequence elements are required for efficient splicing of Simian Virus 40 small-t antigen pre-mRNA. Molec. cell. Biol. 8, 3582–3590 (1988).
Smith, C.W.J., Porro, E.B., Patton, J.G. & Nadal-Ginard, B. Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns. Nature 342, 243–247 (1989).
Hoffman, E.P. et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. New Engl. J. Med. 318, 1363–1368 (1988).
Beggs, A.H. et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. hum. Genet. 49, 54–67 (1991).
Koenig, M., Monaco, A.P. & Kunkel, L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219–226 (1988).
Fong, P.Y., Turner, P.R., Denetclaw, W.F. & Steinhardt, R.A. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250, 673–676 (1990).
Ohlendieck, K. & Campbell, K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. cell Biol. 115, 1685–1694 (1991).
Ibraghimov-Beskrovnaya, O. et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696–702 (1992).
Hoffman, E.P. et al. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann. Neurol. 30, 605–610 (1991).
Roberts, R.G., Bobrow, M. & Bentley, D.R. Point mutations in the dystrophin gene. Proc. natn. Acad. Sci. U.S.A. 89, 2331–2335 (1992).
Towbin, J.A. et al. Characterization of patients with glycerol kinase deficiency utilizing cDNA probes for the Duchenne muscular dystrophy locus. Hum. Genet. 83, 122–126 (1989).
Ochman, H., Medhora, M.M., Garza, D. & Hartl, D.L. Amplification of flanking sequences by inverse PCR. in PCR Protocols. A Guide to Methods and Applications (eds Innis, et al.) 219–227 (Academic, San Diego, 1990).
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).
Frohman, M.A., Dush, M.K. & Martin, G.R. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. natn. Acad. Sci. U.S.A. 85, 8998–9002 (1988).
Jaynes, J.B., Chamberlain, J.S., Buskin, J.N., Johnson, J.E. & Hauschka, S.D. Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Molec. cell. Biol. 6, 2855–2864 (1986).
Burrow, K.L. et al. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology 41, 661–666 (1991).
Kaatz, K.W., Bazzett, T.J. & Albin, R.L. A new, simple myelin stain. Brain Res. Bull. 29, 697–698 (1992).
Maconochie, M.K., Brown, S.D. & Greenfield, A.J. Sequence analysis of two exons from the murine dystrophin locus. Mam. Genome. 2, 64–68 (1992).
About this article
Cite this article
Cox, G., Phelps, S., Chapman, V. et al. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet 4, 87–93 (1993). https://doi.org/10.1038/ng0593-87
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021)
Live‐imaging of revertant and therapeutically restored dystrophin in the Dmd EGFP‐mdx mouse model for Duchenne muscular dystrophy
Neuropathology and Applied Neurobiology (2020)
Disease Models & Mechanisms (2020)
Molecular Neurobiology (2020)
Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies